Interval therapy to avoid nitrate tolerance: paradise regained?

No abstract is available for this paper.

• Publication year

  1989

• Venue

  American Journal of Cardiology

• Publication date

  1989-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9149(89)90844-8PMID 2508456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Limited usefulness of intermittent nitroglycerin patches in stable angina.

  1989cited by this paper
• Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.

  1989cited by this paper
• Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina.

  1989cited by this paper
• Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location.

  1988cited by this paper
• Prevention and Reversal of Nitrate Tolerance in Patients with Congestive Heart Failure

  1988cited by this paper
• Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.

  1988cited by this paper
• Antianginal effects of intravenous nitroglycerin over 24 hours.

  1988cited by this paper
• Mechanisms for the pharmacologic interaction of organic nitrates with thiols. Existence of an extracellular pathway for the reversal of nitrate vascular tolerance by N-acetylcysteine.

  1988cited by this paper
• Sustained antianginal efficacy of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval.

  1988cited by this paper
• Prevention and reversal of nitrate tolerance in patients with congestive heart failure.

  1987cited by this paper
• [Interval therapy in effective treatment of angina pectoris using nitroglycerin patch systems. A controlled study with determination of nitroglycerin plasma levels].

  1987cited by this paper
• Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.

  1987cited by this paper
• Isosorbide‐5‐mononitrate in angina pectoris: Plasma concentrations and duration of effects after acute therapy

  1987cited by this paper
• Effect of intervals between doses on the development of tolerance to isosorbide dinitrate.

  1987cited by this paper
• In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries.

  1987cited by this paper
• Induction and circumvention of nitrate tolerance applying different dosage intervals.

  1987cited by this paper
• Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application.

  1987cited by this paper
• Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris.

  1987cited by this paper
• Prevention of tolerance to nitroglycerin patches by overnight removal.

  1987cited by this paper
• Hemodynamic effects of intermittent transdermal nitroglycerin in chronic congestive heart failure.

  1987cited by this paper
• Nitrate tolerance.

  1987cited by this paper
• Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study

  1987cited by this paper
• Tolerance to organic nitrates

  1986cited by this paper
• Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure

  1986cited by this paper
• A multicenter trial of transdermal nitroglycerin in exercise-induced angina: individual antianginal response after repeated administration.

  1986cited by this paper
• Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

  1986cited by this paper
• Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure

  1986cited by this paper
• Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin.

  1986cited by this paper
• Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.

  1986cited by this paper
• Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris.

  1985cited by this paper
• [Specificity and normality of peripheral systolic pressure measurement by the ultrasound Doppler technic in healthy angiography-imaged extremities].

  1985cited by this paper
• Dose requirements and hemodynamic effects of transdermal nitroglycerin compared with placebo in patients with congestive heart failure.

  1985cited by this paper
• Failure of transdermal nitroglycerin to improve exercise capacity in patients with angina pectoris.

  1985cited by this paper
• Mechanisms and therapy of silent myocardial ischemia and the effect of transdermal nitroglycerin.

  1985cited by this paper
• Tolerance and Rebound Phenomena in Nitrate Therapy

  1985cited by this paper
• Mechanisms of nitrate-induced vasodilatation and tolerance on a biochemical base.

  1985cited by this paper
• Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris.

  1985cited by this paper
• Pharmacology of nitroglycerin and long-acting nitrates.

  1985cited by this paper
• Efficacy of sustained-release buccal nitroglycerin in patients with angina pectoris. New and long-acting therapy demonstrated by exercise.

  1983cited by this paper
• Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine.

  1983cited by this paper
• Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.

  1981cited by this paper
• Nitrate tolerance and dependence.

  1980cited by this paper

• Possible usefulness of apocynin, an NADPH oxidase inhibitor, for nitrate tolerance: prevention of NO donor-induced endothelial cell abnormalities.

  2007cites this paper
• [Nitrates. The place in contemporary therapy of ischemic heart disease].

  2005cites this paper
• Effects of a nitrate-free interval on tolerance, vasoconstrictor sensitivity and vascular superoxide production.

  2000cites this paper
• Attenuation of anti-ischemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris.

  1999cites this paper
• Nitrates in Left Ventricular Dysfunction and Congestive Heart Failure

  1998cites this paper
• Impaired modulation of sympathetic excitability by nitric oxide after long-term administration of organic nitrates in pigs.

  1998cites this paper
• Effects of Amlodipine and Isosorbide Dinitrate on Exercise-Induced and Ambulatory Ischemia in Patients with Chronic Stable Angina Pectoris

  1997cites this paper
• Effect of pre-treatment with transdermal glyceryl trinitrate on myocardial ischaemia during coronary angioplasty.

  1996cites this paper
• Magnitude and Nature of Noncompliance with Treatment using Isosorbide Dinitrate in Patients with Ischemic Heart Disease

  1996cites this paper
• Which drug to choose for stable angina pectoris: a comparative study between bisoprolol and nitrates.

  1995cites this paper
• Effects of bisoprolol and isosorbide dinitrate on the circadian distribution of myocardial ischemia

  1995cites this paper
• Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.

  1995cites this paper
• Physicians cannot be educated in isolation from public concerns, ACMC conference told.

  1994cites this paper
• Lack of Pharmacologic Tolerance and Rebound Angina Pectoris during Twice-Daily Therapy with Isosorbide-5-Mononitrate

  1994cites this paper
• Effects of lisinopril and nitroglycerin on blood pressure early after myocardial infarction: The GISSI‐3 pilot study

  1994cites this paper
• Efficacy of intermittent (eight hours off) transdermal nitrate therapy in stable angina.

  1994cites this paper
• Risk of rebound phenomenon during nitrate withdrawal.

  1994cites this paper
• Mechanisms of the vasodilator action of nitrates and the development of nitrate tolerance (review)

  1993cites this paper
• [The use of angiotensin-converting enzyme inhibitors in patients with ischemic heart disease].

  1993cites this paper
• Acute and long-term effects on myocardial ischemia of intermittent and continuous transdermal nitrate therapy in stable angina.

  1992cites this paper
• An update on nitrate tolerance: can it be avoided?

  1992cites this paper
• Influence of isosorbide-5-mononitrate on the circadian rhythm of angina pectoris.

  1992cites this paper
• Placebo effect of nitrate monotherapy for myocardial ischemia.

  1992cites this paper
• Development of nitrate tolerance and usefulness of pulse therapy in a patient with vasospastic angina.

  1992cites this paper
• Enhancement of the efficacy of isosorbide dinitrate by captopril in stable angina pectoris.

  1992cites this paper
• Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.

  1992cites this paper
• Chronic stable angina pectoris: Risk stratification and treatment

  1992cites this paper
• Avoiding nitrate tolerance.

  1992cites this paper
• Use of nitrates in ischemic heart disease.

  1992cites this paper
• Anupdate onnitrate tolerance: canitbeavoided?

  1992cites this paper
• [The ability of captopril to enhance the anti-anginal effect of isosorbide dinitrate in patients with stable exercise-induced angina pectoris].

  1991cites this paper
• Clinical aspects of nitrate tolerance.

  1991cites this paper
• Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention.

  1991cites this paper
• Slow release isosorbide-5-mononitrate therapy in angina pectoris. Effects of exercise performance and hemodynamics.

  1991cites this paper
• Interactions between organic nitrates and thiol groups.

  1991cites this paper
• Organic nitrate esters: clinical use and mechanisms of actions.

  1991cites this paper
• Recovery of vascular smooth muscle relaxation from nitroglycerin-induced tolerance following a drug-free interval. A time-course in vitro study.

  1991cites this paper
• Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.

  1990cites this paper
• The rapid onset of nitrate tolerance.

  1990cites this paper
• [Methods for evaluating vasodilator agents in cardiac failure].

  1990cites this paper
• Transdermal Nitroglycerin (Glyceryl Trinitrate

  1990cites this paper